Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Granules India Ltd. is a prominent pharmaceutical company engaged in the production and distribution of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages. The company plays a crucial role in the pharmaceuticals sector by providing cost-effective and high-quality solutions across various therapeutic areas, including pain management, gastroenterology, diabetes, and cardiovascular diseases. Granules India Ltd. is recognized for its expansive manufacturing capabilities and integrated operations, allowing it to efficiently produce and deliver large volumes to meet global demand. Headquartered in Hyderabad, India, it serves a diverse clientele that includes major pharmaceuticals around the world. Granules India Ltd.'s strategic approach emphasizes innovation, quality compliance, and sustainability, solidifying its position as a key player in the global pharmaceutical supply chain.